Sanofi raises outlook as specialty care, vaccines lift sales


The French drugmaker said it now expected earnings per share to increase 7%-8% this year, up from 6%-7% previously.

PARIS: Sanofi raised its 2020 earnings guidance for the second time this year after posting slightly stronger-than-expected third-quarter results, helped by growth at its specialty care and vaccines units.

The French drugmaker said it now expected earnings per share to increase 7%-8% this year, up from 6%-7% previously.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Sanofi , french , drugmaker , vaccine , outlook ,

   

Next In Business News

InNature buys 'Burger & Lobster' franchise, eyes expansion into F&B Sector
Bank Negara fines Habib with RM96,250 for AMLA non-compliance
Pharmaniaga says 'stands firm' on financial recovery to exit PN17
Kobay gets UMA query from Bursa Malaysia
LFE gets RM8.27mil piling work
Jiankun expects GDV of its projects to soar to RM2bil under new leadership
Paramount acquires 21.54% stake in Eco World International
CIMB Securities aims for high single-digit market share by year-end
FBM KLCI retraces earlier losses to close flat
Total Dynamic gets bursa's nod to list on LEAP Market

Others Also Read